Physician profile
Michael S Sweeney
NPI 1013912690
$1,475.46
in general payments reported to CMS, 2019-2025
11 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $16.26 · 2021: $215 · 2022: $250 · 2023: $193 · 2024: $399 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $791.82 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Baxter Healthcare | $142.37 | 2024 | Preveleak |
| Cook Medical LLC | $135.04 | 2025 | Litho 150 |
| Acutus Medical, INC. | $134.65 | 2019 | |
| Livanova USA, INC. | $93.19 | 2019 | |
| Heartflow, INC. | $50.00 | 2021 | |
| Medinc of Texas | $35.62 | 2024 | |
| Medtronic, INC. | $31.08 | 2021 | |
| Janssen Pharmaceuticals, INC | $27.30 | 2021-2022 | |
| Baylis Medical Technologies INC. | $18.13 | 2024 | |
| Pfizer INC. | $16.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sweeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.